 Cullum N, Dumville JC,
Nelson EA, et al; VenUS II team. Cost-effectiveness analysis of larval
therapy for leg ulcers. BMJ 2009;338:b825.
236. Dall L, Peterson S, Simmons T, Dall A. Rapid resolution of cellulitis in
patients managed with combination antibiotic and anti-inﬂammatory
therapy. Cutis 2005;75:177-80.
237. Khawcharoenporn T, Tice A. Empiric outpatient therapy with
trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for
cellulitis. Am J Med 2010;123:942-50.
238. Madaras-Kelly KJ, Remington RE, Oliphant CM, Sloan KL,
Bearden DT. Efﬁcacy of oral beta-lactam versus non-beta-lactam
treatment of uncomplicated cellulitis. Am J Med 2008;121:419-25.
239. Kilburn SA, Featherstone P, Higgins B, Brindle R. Interventions for
cellulitis and erysipelas. Cochrane Database Syst Rev 2010;6:
CD004299.
240. Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller M, Rothman A,
Woo K. Bacteriology, inﬂammation, and healing: A study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin
Wound Care 2007;20:549-58.
241. Lantis JC 2nd, Gendics C. In vivo effect of sustained-release silver
sulphadiazine foam on bioburden and wound closure in infected
venous leg ulcers. J Wound Care 2011;20:90-6.
242. Schraibman IG. The signiﬁcance of beta-haemolytic streptococci in
chronic leg ulcers. Ann R Coll Surg Engl 